Showing 1 - 10 of 7,559
discrimination is possible. -- Health systems ; Pharmaceuticals ; Innovation ; Income Based Subsidies ; price discrimination …
Persistent link: https://www.econbiz.de/10003814424
Competition plays an ambiguous role in nursing home markets where public and private payers coexist. Using U.S. nursing home data with a wide range of market structures, we find a U-shaped relationship between competition and service quality when nursing homes serve a mix of public and private...
Persistent link: https://www.econbiz.de/10011800599
In health markets, government policies tend to subsidize poorer groups. The purpose of this paper is to analyze the implications of an income-based subsidy policy on the incentives of countries to implement price arbitrage and of firms to provide market access to poorer groups. --...
Persistent link: https://www.econbiz.de/10003784962
We present a policy game where a Rich country has a higher capacity than a Poor country to commit to certain elements of health policy such as providing income related price subsidies and allowing parallel imports (PI). When allowing PI is not a choice for the Poor country, the Rich country...
Persistent link: https://www.econbiz.de/10008749658
limits of the available resources. In this opinion paper, innovation aspects in medicine, healthcare, and health policy …
Persistent link: https://www.econbiz.de/10013251174
This paper aims at investigating the presence of extra profits for the factoring companies operating with health sector credits. Using a panel data sample representative of Italian factoring companies, the analysis also examines, along with other factors, the determinants of corporate financial...
Persistent link: https://www.econbiz.de/10013026543
In 2002, New Zealand's government-funded primary health care payments were changed from a fee-for-service basis to a capitation basis as part of a change towards a population-based, managed care style of primary health care provision. However, some specific differences characterise the New...
Persistent link: https://www.econbiz.de/10012717521
U.S. federal and state governments rarely regulate healthcare price levels, but do regulate price changes for pharmaceuticals, hospitals, and health insurance. Previous research showed that limiting price increases can raise launch prices and reduce both profit and social welfare, assuming...
Persistent link: https://www.econbiz.de/10011617425
A common reform used to increase consumer choice and competition in public services has been to allow private providers to compete with public incumbents. However, there remains a concern that not all consumers are able to benefit equally from wider choice. We consider the case of publicly...
Persistent link: https://www.econbiz.de/10011718861
Persistent link: https://www.econbiz.de/10013192555